LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$0.57
-0.02 (-2.63%)
Open$0.60
Previous Close$0.58
Day High$0.61
Day Low$0.56
52W High$1.55
52W Low$0.46
Volume—
Avg Volume78.7K
Market Cap13.39M
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,557.3% upside
Current
$0.57
$0.57
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 971.7K | 696.5K | 9.47M |
| Net Income | -16,391,937 | -10,574,685 | 1.90M |
| Profit Margin | -1,686.0% | -1,601.7% | 20.1% |
| EBITDA | -16,282,872 | -11,087,899 | 3.60M |
| Free Cash Flow | — | — | 1.11M |
| Rev Growth | +39.5% | +39.5% | +1.1% |
| Debt/Equity | — | — | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |